咨询与建议

限定检索结果

文献类型

  • 2 篇 期刊文献

馆藏范围

  • 2 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 2 篇 医学
    • 2 篇 临床医学

主题

  • 1 篇 optical coherenc...
  • 1 篇 网络协议
  • 1 篇 病性
  • 1 篇 central serous c...
  • 1 篇 糖尿病视网膜病变
  • 1 篇 multifocal elect...
  • 1 篇 黄斑
  • 1 篇 早期治疗
  • 1 篇 血管内皮生长因子
  • 1 篇 macular microper...
  • 1 篇 水肿
  • 1 篇 业绩
  • 1 篇 fundus autoflour...

机构

  • 1 篇 department of op...
  • 1 篇 department of op...

作者

  • 2 篇 rita ehrlich
  • 2 篇 michal schaap-fo...

语言

  • 2 篇 英文
检索条件"作者=michal schaap-fogler"
2 条 记 录,以下是1-10 订阅
排序:
What is the best anti-vascular endothelial growth factor agent for the treatment of diabetic macular edema? Review of the 2-year results of Diabetic Retinopathy Clinical Research Network ProtocolT
收藏 引用
Eye Science 2016年 第4期31卷 217-220页
作者: michal schaap-fogler Rita Ehrlich Department of Ophthalmology Rabin Medical Center Sackler School of Medicine Tel Aviv University Tel Aviv Israel
Diabetic macular edema(DME) remains a main concern in diabetic patients,due to potential visual impairment with any level of diabetic *** first study to provide a treatment option for these patients was The Early Trea... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
What is new in central serous chorioretinopathy?
收藏 引用
World Journal of Ophthalmology 2014年 第4期4卷 113-123页
作者: michal schaap-fogler Rita Ehrlich Department of Ophthalmology Rabin Medical CenterPetach Tikva 49100 Israel
Central serous chorioretinopathy(CSCR) is considered a benign, self-limiting disease. However, as many as third of the patients have recurrent episodes or chronic disease that may cause significant functional impairme... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论